What next for trade events?

In this special events-themed episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Samuel Thangiah, co-founder of Life Science Integrates Tara Dougal, Head Of Content & Insights for Pharma at Informa Markets Edward McNamara, Vice President of Innovation Banking - Life Sciences at Cambridge Trust and the Co-Founder of BioXchange Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology event scene with his three guests, covering: The impact on event organisers and the pivot required over the last 18 months including the birth of the smart/hybrid event model. The side effect benefits of virtual events including international reach and even better speakers. A look forward to what local, regional, national and international trade events may look like in the future. And, how you and your organisation should be thinking about, approaching and planning for events in 2022. Samuel is Co-Founder and Executive Director of Life Science Integrates. Life Science Integrates produces the debate-led events shaping conversations in Pharma, BioTech and MedTech. Tara is Head of Content and Insights for the Pharma Portfolio at Informa Markets, where she has worked since 2015. In this role, Tara leads the digital and live content strategy for CPhI Worldwide, Pharmapack Europe and CPhI North America. Ed is Vice President of Innovation Banking at Cambridge Trust and has both a life sciences and banking background. Prior to joining Cambridge Trust, Ed worked on business development for Biotech Vendor Services. Ed also co-founded a very successful networking group, BioXchange Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.